As of 2024-12-14, the Fair Value of Promore Pharma AB (PROMO.ST) is -1.89 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.70 SEK, the upside of Promore Pharma AB is -119.47%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -32.48 | -28.87 | -29.45 | -26.77 | -26.62 | -28.84 |
| YoY growth | -279.12% | 11.14% | -2.02% | 9.09% | 0.57% | -52.07% |
| Market Cap (mil) | 6.20 |
| P/E | |
| Forward P/E |
| EPS | -0.38 |
| Avg earnings growth rate | -52.07% |
| TTM earnings | -22.93 |